Milton H. Werner, Ph.D.

Milton H. Werner, Ph.D.

Former President and Chief Executive OfficeratInhibikase Therapeutics· In proxies 2022–2025

Pay in FY2025-90% from the year before · Inhibikase Therapeutics stock -36.9% the same year

Milton H. Werner, Ph.D. was paid $803.1K in FY2025 (Dec), down 90%. Inhibikase Therapeutics stock fell 36.9% that year.

Pay$100 in the stock at the end of FY21 → $23
Pay is from the Summary Compensation Table of each Inhibikase Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Inhibikase TherapeuticsPublic company · 4 yr
    • Former President and Chief Executive Officer2022 – Present · 4 yrStock in role -83%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?